fda glp-1 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Approves Oral Semaglutide: First

How Marketing Exploits Scientific Language Cherry-picking studies: Marketing materials cite research demonstrating GLP-1 increases while omitting discussion of effect sizes, duration, or clinical outcomes

The AACE Clinical Case Reports 2024 issue featured a 20-year-old man being treated for obesity with tirzepatide, another GLP-1 receptor agonist

BPC-157 was first formally described in the Journal of Physiology, Paris, in 1993, according to a commentary published in Inflammopharmacology

Both types work synergistically to support skin hydration during fasting periods

Palana, C., Aburumman, A., Kachungunu, C

By promoting tissue repair, peptides like BPC-157, TB-500, and GHK-Cu may help to maintain the skins integrity, reduce the appearance of scars, and improve overall skin texture